See All Slides -

Slides

Presentation TCT 2015

Transcatheter Tricuspid Regurgitation Treatment 2: Mitralign

Presenter: Rebecca T. Hahn, Joachim Schofer

October 15, 2015

Presentation TCT 2015

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Presenter: Isaac George, Augusto D. Pichard, Susheel Kodali

October 15, 2015

Presentation TCT 2015

What Is the Optimal Anticoagulant for Transradial PCI?

Presenter: Olivier F. Bertrand, John A. Bittl

October 15, 2015

Presentation TCT 2015

Insights From OCT and IVUS in LM Bifurcations: Lessons From DOCTOR Left Main

Presenter: David E. Kandzari, Niels R. Holm

October 15, 2015

Presentation TCT 2015

Endo-Tension and Its Implications: A Primer

Presenter: Jacques Busquet, Christopher K. Zarins

October 15, 2015

$Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?$

Presentation TCT 2015

Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?

Presenter: Carlo Briguori, Roxana Mehran, Carey D. Kimmelstiel

October 15, 2015

Presentation TCT 2015

Transcatheter Tricuspid Regurgitation Treatment 1: MitraClip

Presenter: Rebecca T. Hahn, Joachim Schofer, Brij Maini

October 15, 2015

Presentation TCT 2015

The Biolute BRS: Differentiating Features and Clinical Update

Presenter: Alexandre Abizaid, Pieter C. Smits, Dinesh Shah

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn

October 15, 2015

Presentation TCT 2015

Bleeding Events (Early and Late) After TAVR: Growing Importance and Often Misunderstood

Presenter: Isaac George, Augusto D. Pichard, Philippe Généreux

October 15, 2015

Advertisement

Slides

Transcatheter Tricuspid Regurgitation Treatment 2: Mitralign

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

What Is the Optimal Anticoagulant for Transradial PCI?

Insights From OCT and IVUS in LM Bifurcations: Lessons From DOCTOR Left Main

Endo-Tension and Its Implications: A Primer

Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?

Transcatheter Tricuspid Regurgitation Treatment 1: MitraClip

The Biolute BRS: Differentiating Features and Clinical Update

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Bleeding Events (Early and Late) After TAVR: Growing Importance and Often Misunderstood

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content